Rawcliffe Adrian's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Dec 10, 2025
- Accession no.
- 0001193125-25-314742
- Filed
- Dec 10, 2025
- Trade date
- Dec 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $630.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rawcliffe AdrianCIK 0001555851 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Ordinary Shares | MOption exerciseAcquired | +42,000 | $5.97 | +$250,740 | 54,700 | Direct | |
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −42,000 | $15.00 | −$630,000 | 12,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Ordinary Shares | MOption exerciseDisposed | −42,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.